Le Lézard
Classified in: Health

Modality Solutions Announces 2019 Year-End Milestones Including ISO 9001:2015, Inc. 5000, Entrepreneur 360tm and More


HOUSTON, Jan. 21, 2020 /PRNewswire-PRWeb/ -- Modality Solutions specializes in integrating cold chain operations, developing transport validation strategies, supporting global regulatory applications, and executing global clinical trial operations. Milestone highlights include recognition by both Inc. 5000 and the Houston Business Journal as a fastest growing company, and ISO 9001:2015 certification with the scope of the accreditation covering consulting, design and engineering services and testing for supply chain logistics related to transport-sensitive drug products.

Modality Solutions also received the distinction of being one of the "Best Entrepreneurial Companies in America" by Entrepreneur magazine on its 2019 Entrepreneur 360tm List. "Our annual evaluation is a 360-degree analysis of top privately-held companies representing and serving a variety of industries," explains Lisa Murray, Chief Insights Officer of Entrepreneur Media, Inc. "These businesses are real-world case studies for any entrepreneur who seeks to master the four pillars that can greatly impact the longevity and growth of their businesses. With the Entrepreneur 360, success is measured by achieving balance throughout the entire organization, predicated by revenue."

Co-founder and President, Gary Hutchinson, was accepted into Forbes Technology Council, an invitation-only community for world-class CIOs, CTOs, and technology executives. Hutchinson was vetted and selected by a review committee based on the depth and diversity of his experience. Criteria for acceptance include a track record of successfully impacting business growth metrics, as well as personal and professional achievements and honors.

Modality Solutions achieved its first-ever ranking on Inc. Magazine's annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing private companies. It reported a three-year revenue growth of 120 percent and ranked No. 47 in the Inc. industry category of top engineering companies. Also, in its first appearance on the Houston Business Journal's Fast 100 list, the company ranked No. 91 with reported two-year revenue growth of 56 percent.

"2019 was a stellar year for us, with ISO 9001:2015 certification, recognition by Inc. and Entrepreneur magazines, participation in the Forbes Tech Council, and continuing to partner with our clients to validate safe and effective cold chains," said President Hutchinson. "As we continue our mission into the next decade, our vision for the future is to continue to expand with our team of experienced engineers our ongoing role to promote safe, effective, and validated cold chain for a whole range of therapies."

The company's commitment to growth included promoting from within Andrew Larrigan and Robert Battista to Senior Consulting Engineers and adding Rachel Sawyer as Consulting Engineer. In her new position, Sawyer works with other dedicated project engineers to ensure proper design and use of cold chain systems.

The biopharmaceutical industry benefited from Modality Solutions' first live webinar on Sept. 19. Principals Gary Hutchinson and Daniel Littlefield covered a step-by-step cold chain validation process to help pharmaceutical companies meet and exceed increasingly stringent regulatory expectations, including monoclonal antibodies, antibody-drug conjugates, and cell therapies. To access the on-demand replay of "Cold Chain Validation Best Practices Including Immunotherapy" go to https://modality-solutions.securechkout.com/cold-chain-validation-best-practices-webinar.

To wrap up its year of achievements, Modality Solutions was a Silver Sponsor and cold chain validation workshop presenter at the Biomanufacturing World Summit (BMWS19) Conference, November 11-12, 2019, at the Hilton La Jolla Torrey Pines in San Diego, California. Hutchinson and Littlefield presented "Cold Chain Validation Best Practices Including Immunotherapy."

To learn more about Modality Solutions, visit https://www.modality-solutions.com.

About Modality Solutions, LLC
Founded in 2011, Modality Solutions, a leading biopharmaceutical cold chain engineering firm, specializes in integrating cold chain operations, developing transport validation strategies, supporting global regulatory applications, and executing global clinical trial operations. By combining the best practices of process validation, systems qualification, and risk assessment, Modality Solutions has earned the reputation of ensuring regulatory compliance, product quality, and patient safety. As an ISO 9001:2015 certified, Inc. 5000, Houston Business Journal Fast 100, Entrepreneur 360tm, and Forbes Technology Council company, Modality Solutions' team of engineers are experts at delivering cold chain thermal packaging design and qualification, conducting transport simulation testing with its Advantage Transport Simulation Laboratorytm, and designing controlled-environment logistics solutions. For more information, visit https://www.modality-solutions.com.

 

SOURCE For Modality Solutions


These press releases may also interest you

at 22:48
Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28® has launched innovative products and instrumentation that help streamline...

at 21:45
Biotech Institute, LLC, the global leader in hemp and cannabis plant breeding, science, and innovation, and Booshoot, LLC ("Booshoot") announced today that they have finalized a groundbreaking technology licensing agreement that will set a new...

at 21:00
UBM BN Co., Ltd., the fair manager of SECON 2020 originally scheduled for 18 - 20 March 2020 has made the decision to reschedule the event to 6 - 8 July at KINTEX, Korea.   The decision is taken after careful consideration and close consultations...

at 20:42
Nanalysis Scientific Corp. ("Nanalysis", TSXV:NSCI) is pleased to announce that it won the award for 'Best New Analytical Product' at the recent Nanotech Exhibition and Conference in Tokyo, Japan. Nanalysis was the only small-cap, non-Japanese...

at 20:22
Vanda Pharmaceuticals Inc. (Vanda) today announced it will release results for the fourth quarter and full year 2019 on Tuesday, February 25, 2020, after the market closes.   Vanda will host a conference call at 4:30 PM ET on Tuesday, February 25,...

at 20:05
Gilead Sciences, Inc. today announced that Johanna Mercier, Chief Commercial Officer, and Merdad Parsey, MD, PhD, Chief Medical Officer, will participate in a fireside chat at the Cowen and Company 40th Annual Health Care Conference in Boston on...



News published on 21 january 2020 at 06:00 and distributed by: